Bruker Corporation Reports Q1 2026 Revenue of $823.4 Million, Driven by Service Growth

Bruker Corporation reported its financial results for the first quarter of 2026, revealing total revenue of $823.4 million, a 2.7% increase from $801.4 million in the same period last year. The growth was primarily driven by a 12% rise in service and other revenue, which reached $177.0 million, while product revenue saw a modest increase of 0.5% to $646.4 million. However, the company's gross profit declined to $379.8 million, resulting in a gross profit margin of 46.1%, down from 48.8% in the prior year. Operating income also fell significantly to $10.2 million, compared to $31.8 million in Q1 2025, reflecting increased operating expenses and restructuring costs.

In terms of operational changes, Bruker completed the acquisition of Tofwerk AG on January 6, 2026, enhancing its mass spectrometry portfolio. This acquisition is expected to strengthen Bruker's position in advanced environmental and industrial markets. The company also reported a significant increase in restructuring charges, totaling $10.4 million, as part of a corporate-wide initiative aimed at improving cost efficiencies and aligning product offerings with market demands. The restructuring plan is anticipated to be completed by the end of 2026.

Geographically, Bruker experienced varied performance, with revenue from North America slightly declining by 0.2%, while European revenue increased by 12.8%. However, revenue from Asia Pacific, particularly China, decreased by 10.3%. The company noted that the decline in the Chinese market was a significant factor affecting overall performance. The BSI CALID segment, which includes the newly acquired Tofwerk, reported a 12.9% increase in revenue, indicating strong demand in applied markets.

Bruker's cash position as of March 31, 2026, stood at $133.4 million, a decrease from $298.8 million at the end of 2025. The company reported net cash provided by operating activities of $71.2 million, up from $65.0 million in the previous year. However, net cash used in financing activities surged to $204.9 million, primarily due to repayments of long-term debt and dividend payments. Looking ahead, Bruker anticipates that its existing cash and credit facilities will be sufficient to support its operational and investment needs for the foreseeable future, despite the ongoing challenges in the global market.